![Real-world comparison of Docetaxel versus new hormonal agents in combination with androgen-deprivation therapy in metastatic hormone-sensitive prostate cancer descrying PSA Nadir ≤ 0.05 ng/ml as marker for treatment response | SpringerLink Real-world comparison of Docetaxel versus new hormonal agents in combination with androgen-deprivation therapy in metastatic hormone-sensitive prostate cancer descrying PSA Nadir ≤ 0.05 ng/ml as marker for treatment response | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00345-022-04189-8/MediaObjects/345_2022_4189_Fig2_HTML.png)
Real-world comparison of Docetaxel versus new hormonal agents in combination with androgen-deprivation therapy in metastatic hormone-sensitive prostate cancer descrying PSA Nadir ≤ 0.05 ng/ml as marker for treatment response | SpringerLink
![SciELO - Brasil - Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens Importance of prostate-specific antigen (PSA) as SciELO - Brasil - Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens Importance of prostate-specific antigen (PSA) as](https://minio.scielo.br/documentstore/1980-5322/ZdXYZDQJjyz5bwTwycytYSf/c69c318fa286be08faab4025fd7ca42001f2f92a.jpg)
SciELO - Brasil - Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens Importance of prostate-specific antigen (PSA) as
Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value | PLOS ONE
![Single Subject Studies in Prostate Cancer: How graphing PSA test results and testosterone levels using Process Behavior and Celeration Charts can provide insight and guide clinical decisions Single Subject Studies in Prostate Cancer: How graphing PSA test results and testosterone levels using Process Behavior and Celeration Charts can provide insight and guide clinical decisions](https://www.oncogen.org/userfiles/images/101.png)
Single Subject Studies in Prostate Cancer: How graphing PSA test results and testosterone levels using Process Behavior and Celeration Charts can provide insight and guide clinical decisions
![Distance scaling for median PGA and median PSA at 0.05, 0.2 and 1.0 s... | Download Scientific Diagram Distance scaling for median PGA and median PSA at 0.05, 0.2 and 1.0 s... | Download Scientific Diagram](https://www.researchgate.net/publication/364326206/figure/fig3/AS:11431281094041015@1667357758441/Distance-scaling-for-median-PGA-and-median-PSA-at-005-02-and-10s-for-magnitude-M-60.png)
Distance scaling for median PGA and median PSA at 0.05, 0.2 and 1.0 s... | Download Scientific Diagram
![PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome – 5 year follow-up of a prospective observational study - ScienceDirect PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome – 5 year follow-up of a prospective observational study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2405630820300434-gr3.jpg)